After a clinical trial killed one person and landed five others in intensive care, the government is demanding that the clinical trial company responsible, Biotrial, provide a “plan of action” for admitting and addressing mistakes within a month or risk losing its license.
Support MIA
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.